Cantillo, E., Zemla, T. J., Moroney, J. W., Alvarez, E. A., Yauch, L., Lin, Y. G., … Slomovitz, B. M. (2023). AFT-50 EndoMAP: A phase IB/II multi-cohort study of targeted agents for patients with recurrent or persistent endometrial cancer. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 41).

Cantillo, Evelyn, Tyler J. Zemla, John William Moroney, Edwin A. Alvarez, Lauren Yauch, Yvonne Gail Lin, JaneMichelle Michelle Brockman, et al. “AFT-50 EndoMAP: A phase IB/II multi-cohort study of targeted agents for patients with recurrent or persistent endometrial cancer.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 41, 2023.

Cantillo E, Zemla TJ, Moroney JW, Alvarez EA, Yauch L, Lin YG, et al. AFT-50 EndoMAP: A phase IB/II multi-cohort study of targeted agents for patients with recurrent or persistent endometrial cancer. In: JOURNAL OF CLINICAL ONCOLOGY. 2023.

Cantillo, Evelyn, et al. “AFT-50 EndoMAP: A phase IB/II multi-cohort study of targeted agents for patients with recurrent or persistent endometrial cancer.” JOURNAL OF CLINICAL ONCOLOGY, vol. 41, no. 16, 2023.

Cantillo E, Zemla TJ, Moroney JW, Alvarez EA, Yauch L, Lin YG, Brockman JM, DiLallo G, Liu JF, Secord AA, Nixon AB, Mandrekar SJ, Matulonis UA, Kozono DE, Slomovitz BM. AFT-50 EndoMAP: A phase IB/II multi-cohort study of targeted agents for patients with recurrent or persistent endometrial cancer. JOURNAL OF CLINICAL ONCOLOGY. 2023.